| myeloid sarcoma | ||||
| Disease ID | 598 |
|---|---|
| Disease | myeloid sarcoma |
| Integrated Phenotype | (Waiting for update.) |
| Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:13) HP:0004808 | Acute myelogenous leukemia | 10 HP:0001909 | Leukemia | 7 HP:0012324 | Myeloid leukemia | 7 HP:0002863 | Myelodysplastic syndrome | 2 HP:0004836 | Acute promyelocytic leukemia | 2 HP:0005214 | Bowel obstruction | 1 HP:0002716 | Lymph node hyperplasia | 1 HP:0011880 | Acute disseminated intravascular coagulation | 1 HP:0005506 | Chronic myeloid leukemia | 1 HP:0002664 | Neoplasia | 1 HP:0002960 | Autoimmune condition | 1 HP:0002202 | Pleural effusion | 1 HP:0005521 | Disseminated intravascular coagulation | 1 |
| Disease ID | 598 |
|---|---|
| Disease | myeloid sarcoma |
| Manually Symptom | UMLS | Name(Total Manually Symptoms:2) |
| Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
All Snps(Total Genotypes:4) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
| rs386626619 | 22041374 | 3717 | JAK2 | umls:C0152276 | BeFree | This report describes the first case of myeloid sarcoma with JAK2 V617F mutation and implication of its progression to AML. | 0.000542884 | 2011 | NA | NA | NA | NA | NA |
| rs386626619 | 24118374 | 3717 | JAK2 | umls:C0152276 | BeFree | In addition, homozygous JAK2 V617F mutation was detected from the myeloid sarcoma specimen. | 0.000542884 | 2013 | NA | NA | NA | NA | NA |
| rs77375493 | 24118374 | 3717 | JAK2 | umls:C0152276 | BeFree | In addition, homozygous JAK2 V617F mutation was detected from the myeloid sarcoma specimen. | 0.000542884 | 2013 | JAK2;INSL6 | 9 | 5073770 | G | A,T |
| rs77375493 | 22041374 | 3717 | JAK2 | umls:C0152276 | BeFree | This report describes the first case of myeloid sarcoma with JAK2 V617F mutation and implication of its progression to AML. | 0.000542884 | 2011 | JAK2;INSL6 | 9 | 5073770 | G | A,T |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
Mapped by lexical matching(Total Items:0) |
|---|
| (Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
|---|
| (Waiting for update.) |
Chemical(Total Drugs:1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
| C0152276 | melphalan | D008558 | 148-82-3 | sarcoma, myeloid | MESH:D023981 | marker/mechanism | 11099330 | ||
FDA approved drug and dosage information(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA labeling changes(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |